PRM3

gene
On this page

Summary

PRM3 (protamine 3, HGNC:13732) is a protein-coding gene on chromosome 16p13.13, encoding Protamine-3 (Q9NNZ6). Protamines substitute for histones in the chromatin of sperm during the haploid phase of spermatogenesis.

Predicted to enable DNA binding activity. Predicted to be involved in flagellated sperm motility. Predicted to be located in chromosome and nucleus. Predicted to be part of nucleosome. Predicted to be active in cytoplasm.

Source: NCBI Gene 58531 — RefSeq curated summary.

At a glance

  • GWAS associations: 8
  • Clinical variants (ClinVar): 28 total
  • MANE Select transcript: NM_021247

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13732
Approved symbolPRM3
Nameprotamine 3
Location16p13.13
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000178257
Ensembl biotypeprotein_coding
Entrez58531

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000327157

RefSeq mRNA: 1 — MANE Select: NM_021247 NM_021247

CCDS: CCDS76821

Canonical transcript exons

ENST00000327157 — 1 exons

ExonStartEnd
ENSE000012309591127319911273629

Expression profiles

Bgee: expression breadth ubiquitous, 115 present calls, max score 96.05.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0665 / max 59.5432, expressed in 5 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1562430.05725
2077560.00613
1562440.00322

Top tissues by expression

129 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047396.05gold quality
left testisUBERON:000453394.20gold quality
right testisUBERON:000453493.88gold quality
testisUBERON:000047393.40gold quality
sural nerveUBERON:001548866.05gold quality
cerebellar hemisphereUBERON:000224558.50gold quality
cerebellar cortexUBERON:000212958.31gold quality
right hemisphere of cerebellumUBERON:001489058.11gold quality
cerebellumUBERON:000203757.72gold quality
left uterine tubeUBERON:000130349.33gold quality
bone marrowUBERON:000237147.03gold quality
right lungUBERON:000216746.09gold quality
stromal cell of endometriumCL:000225543.50gold quality
smooth muscle tissueUBERON:000113543.10gold quality
granulocyteCL:000009442.74silver quality
right uterine tubeUBERON:000130242.43silver quality
duodenumUBERON:000211442.37gold quality
cortical plateUBERON:000534341.42gold quality
monocyteCL:000057641.41gold quality
rectumUBERON:000105241.26gold quality
endometriumUBERON:000129541.19gold quality
right ovaryUBERON:000211840.97gold quality
myometriumUBERON:000129640.95gold quality
leukocyteCL:000073840.94gold quality
right frontal lobeUBERON:000281040.05gold quality
small intestine Peyer’s patchUBERON:000345439.76gold quality
fallopian tubeUBERON:000388939.60gold quality
mucosa of stomachUBERON:000119939.43silver quality
bone marrow cellCL:000209239.21gold quality
Brodmann (1909) area 9UBERON:001354038.74gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-134144yes31.34
E-ANND-3no0.32

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): AP1, DNMT1, ZHX2

Literature-anchored findings (GeneRIF, showing 1)

  • Mutations in the protamine locus may be an infrequent cause of male infertility. (PMID:19602509)

Cross-species orthologs

1 orthologs

OrganismSymbolGene ID
mus_musculusPrm3ENSMUSG00000050058

Protein

Protein identifiers

Protamine-3Q9NNZ6 (reviewed: Q9NNZ6)

Alternative names: Sperm protamine P3

All UniProt accessions (1): Q9NNZ6

UniProt curated annotations — full annotation on UniProt →

Function. Protamines substitute for histones in the chromatin of sperm during the haploid phase of spermatogenesis. They compact sperm DNA into a highly condensed, stable and inactive complex.

Subcellular location. Nucleus. Chromosome.

Similarity. Belongs to the protamine P3 family.

RefSeq proteins (1): NP_067070* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026077PRMP3Family

UniProt features (8 total): compositionally biased region 3, chain 1, region of interest 1, modified residue 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NNZ6-F158.430.00

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 95

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 54 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, GSE45365_NK_CELL_VS_CD8A_DC_DN, GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_CHROMOSOME_ORGANIZATION, GOBP_MALE_GAMETE_GENERATION, GOBP_CHROMOSOME_CONDENSATION, YGACNNYACAR_UNKNOWN, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOCC_PROTEIN_DNA_COMPLEX, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, NRL_DN.V1_UP

GO Biological Process (4): spermatogenesis (GO:0007283), cell differentiation (GO:0030154), chromosome condensation (GO:0030261), flagellated sperm motility (GO:0030317)

GO Molecular Function (1): DNA binding (GO:0003677)

GO Cellular Component (4): nucleosome (GO:0000786), nucleus (GO:0005634), cytoplasm (GO:0005737), chromosome (GO:0005694)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
developmental process involved in reproduction1
male gamete generation1
cellular developmental process1
chromosome organization1
cilium-dependent cell motility1
cilium movement involved in cell motility1
sperm motility1
nucleic acid binding1
chromatin1
protein-DNA complex1
intracellular membrane-bounded organelle1
intracellular anatomical structure1
cellular anatomical structure1
intracellular membraneless organelle1

Protein interactions and networks

STRING

362 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PRM3PRM2P04554815
PRM3TNP2Q05952808
PRM3TNP1P09430681
PRM3PRM1P04553541
PRM3ROMO1P60602490
PRM3BRDTQ58F21452
PRM3TMEM225Q6GV28451
PRM3HADHBP55084418
PRM3TBXA2RP21731415
PRM3IZUMO3Q5VZ72412
PRM3TMEM225BP0DP42407
PRM3SPACA3Q8IXA5404
PRM3TSSK6Q9BXA6400
PRM3SYCP1Q15431396
PRM3SOX30O94993384

IntAct

2 interactions, top by confidence:

ABTypeScore
PRM3ARRB2psi-mi:“MI:0914”(association)0.350

ESM2 similar proteins: A0A0U1RQG5, A1L429, A6NDE8, A6NER3, A6NGK3, E1AZ71, O08664, O60829, O75459, O76087, P0C2W7, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P52651, P62521, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q17QW4, Q28181, Q2T9P9, Q32PA2, Q4V321, Q4V326, Q5JQC4, Q5U2Y8, Q62100, Q63803, Q64256, Q6NT46, Q6X7S9, Q7Z2X7

Diamond homologs: Q32PA2, Q62100, Q64256, Q9NNZ6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

28 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance23
Likely benign2
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

110 predictions. Top by Δscore:

VariantEffectΔscore
16:11273441:T:TAdonor_gain0.8800
16:11273481:CA:Cdonor_gain0.8600
16:11273470:AT:Adonor_gain0.7800
16:11273348:T:TAdonor_gain0.7500
16:11273480:A:ACdonor_gain0.7500
16:11273481:C:CCdonor_gain0.7500
16:11273471:T:TAdonor_gain0.7300
16:11273345:T:TAdonor_gain0.6800
16:11273264:T:TAdonor_gain0.6500
16:11273448:CCG:Cacceptor_gain0.6500
16:11273449:CGC:Cacceptor_gain0.6500
16:11273606:G:Adonor_gain0.6500
16:11273447:CCCG:Cacceptor_gain0.6400
16:11273448:CCGC:Cacceptor_gain0.6400
16:11273380:G:Adonor_gain0.6000
16:11273563:G:Adonor_gain0.5900
16:11273451:C:CCacceptor_gain0.5800
16:11273333:T:TAdonor_gain0.5700
16:11273449:CG:Cacceptor_gain0.5600
16:11273602:CG:Cdonor_gain0.5400
16:11273449:C:Tacceptor_gain0.5300
16:11273603:G:Cdonor_gain0.5200
16:11273449:CGCT:Cacceptor_loss0.4900
16:11273450:GCTG:Gacceptor_loss0.4900
16:11273451:CTGAT:Cacceptor_loss0.4900
16:11273452:T:Cacceptor_loss0.4900
16:11273481:CACAG:Cdonor_gain0.4900
16:11273446:G:Adonor_gain0.4800
16:11273454:A:ACacceptor_gain0.4800
16:11273225:T:TAdonor_gain0.4600

AlphaMissense

675 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:11273498:T:AK33I0.918
16:11273476:A:CS40R0.910
16:11273476:A:TS40R0.910
16:11273478:T:GS40R0.910
16:11273471:T:AD42V0.884
16:11273497:T:AK33N0.874
16:11273497:T:GK33N0.874
16:11273484:A:GC38R0.861
16:11273464:G:CF44L0.846
16:11273464:G:TF44L0.846
16:11273466:A:GF44L0.846
16:11273482:A:CC38W0.835
16:11273492:A:GL35P0.833
16:11273483:C:TC38Y0.822
16:11273472:C:GD42H0.818
16:11273471:T:GD42A0.808
16:11273483:C:GC38S0.799
16:11273484:A:TC38S0.799
16:11273375:A:GL74P0.797
16:11273583:A:GC5R0.786
16:11273581:A:CC5W0.779
16:11273372:A:GL75P0.771
16:11273498:T:GK33T0.766
16:11273459:A:GL46S0.760
16:11273582:C:GC5S0.758
16:11273583:A:TC5S0.758
16:11273492:A:TL35H0.757
16:11273375:A:TL74Q0.748
16:11273465:A:GF44S0.740
16:11273500:C:AM32I0.737

dbSNP variants (sampled 300 via entrez): RS1000007335 (16:11273201 C>A), RS1001674418 (16:11274026 C>T), RS1002046271 (16:11274712 G>T), RS1002111087 (16:11273880 A>G), RS1002416832 (16:11274926 C>G), RS1003890829 (16:11274886 T>C), RS1004532263 (16:11274706 T>A), RS1005190632 (16:11273950 G>A), RS1005468394 (16:11274168 T>C), RS1006370777 (16:11272733 T>C), RS1007867149 (16:11274304 C>T), RS1008097954 (16:11275083 C>T), RS1008374860 (16:11274429 C>A,T), RS1009984706 (16:11274081 C>A), RS1010415324 (16:11274280 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

8 associations (top):

StudyTraitp-value
GCST000258_5Type 1 diabetes3.000000e-06
GCST001341_12Multiple sclerosis6.000000e-07
GCST001958_14Bulimia nervosa2.000000e-06
GCST003268_27Psoriasis vulgaris3.000000e-07
GCST004131_115Inflammatory bowel disease1.000000e-06
GCST004132_39Crohn’s disease1.000000e-07
GCST005527_32Psoriasis5.000000e-08
GCST009798_15Asthma2.000000e-33

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:1001494psoriasis vulgaris

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

ChemicalActions (top 5)PubMed papers
Acetaminophendecreases expression1
Benzo(a)pyreneaffects methylation, decreases methylation1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.